Brain Cancer
Angiochem to Present at Stifel Nicolaus Healthcare Conference 2010
Published in Cancer Law Weekly, October 2nd, 2010
Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier through LRP-1 targeting, announced that Jean-Paul Castaigne, MD, President and CEO of Angiochem is scheduled to present a company overview at the Stifel Nicolaus Healthcare Conference at the Four Seasons Hotel in Boston, MA on Thursday, September 16th at 4:25p.m. EDT. About Angiochem // Angiochem is a clinical-stage biotechnology company discovering and developing new breakthrough drugs that are uniquely capable of crossing the blood-brain barrier (BBB) to treat brain diseases. The company's proprietary Engineered Peptide Compounds (EPiC) technology creates...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2010-10-02)
More Articles from Cancer Law Weekly
- Prostate Cancer
AMLU and OPEIU to Present Check to 'Ed Randall's Bat for the Cure' to Help Strike Out Prostate Cancer - Squamous Cell Carcinoma
Affiliated Hospital, Medical College reports research in squamous cell carcinoma - Cancer
American Cancer Society and American Cancer Society Cancer Action Network Team Up with Alpha Kappa Alpha Sorority, Inc. to Reduce Burden of Cancer on African Americans - Attitudes by Renee
Attitudes by Renee Announces New National Awards Program - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
